We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
199 hedge funds and large institutions have $3.7B invested in Acadia Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 71 increasing their positions, 60 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
64% more capital invested
Capital invested by funds: $2.25B → $3.7B (+$1.45B)
57% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 23
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
19% more call options, than puts
Call options by funds: $33M | Put options by funds: $27.8M
18% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 60
7% more funds holding
Funds holding: 186 → 199 (+13)
1.38% less ownership
Funds ownership: 97.22% → 95.84% (-1.4%)
Holders
199
Holders Change
+13
Holders Change %
+6.99%
% of All Funds
4.31%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
36
Increased
71
Reduced
60
Closed
23
Calls
$33M
Puts
$27.8M
Net Calls
+$5.21M
Net Calls Change
+$3.83M
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$30.9M |
| 2 |
D.E. Shaw & Co
New York
|
+$30.1M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$20.5M |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$18.1M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$16.8M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$50.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$43.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$24.8M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$17.6M |
| 5 |
Citigroup
New York
|
-$15.6M |
